Health TrialsbyHealthPanel

Improving Dementia Care in Primary Practice

ConditionsAlzheimer Disease (AD)Mild Cognitive Impairment (MCI)Dementia
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age66+
SponsorThomas Jefferson University

About this trial

This clinical trial will evaluate a multi-level scalable intervention called Improving Dementia Care (IDC). The investigators hypothesize that IDC will increase dementia detection in patients with impaired cognition more than the control condition, Enhanced Usual Care (EUC), over 6 months.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

No previous diagnosis of mild cognitive impairment (MCI) or Alzheimer's disease (AD).

Have a scheduled PCP visit in the next 4-6 weeks

Have subjective cognitive impairment

Score ≥ 26 on the Telephone Interview for Cognitive Status (TICS)

Disqualifiers

EHR evidence or previous cognitive evaluations, diagnosis of MCI or AD, or use of AD medications

TICS score of ≤ 11.00

Inability to provide informed consent

Trial design

Design model

Parallel

Treatments tested in this trial

  • Improving Dementia Care

    Other intervention

    During a phone session, participants receive ADRD Education and Personalized Decision Counseling, which consists of eliciting values and goals to reach informed, preference-based decisions on whether to have an ADRD evaluation. Participants' primary care physicians are sent cognitive screening results and a smart order set (i.e., orders for ADRD-relevant lab and neuroimaging) via the electronic health record (EHR).

  • Enhanced Usual Care

    Other intervention

    Usual care enhanced with notices sent to participants' primary care physicians with cognitive screening results and a smart order set (i.e., orders for ADRD-relevant lab and neuroimaging) via the electronic health record (EHR).

Treatment groups

80 Participants
are divided into 2 treatment groups
Group A: Improving Dementia Care (IDC)Experimental treatment 1 intervention
Group B: Enhanced Usual Care (EUC)Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

Incident cognitive diagnoses.

Chart reviews will identify the number of patients with a new cognitive diagnosis in each arm.

Time frame
6 months

Secondary outcomes

1

Orders for Alzheimer's disease-relevant lab and neuroimaging

Chart reviews will identify the number of patients with a new relevant lab and imaging tests.

Time frame
6 months
2

Prescribed Alzheimer's disease (AD) medications.

Chart reviews will identify the number of patients with a new AD medications.

Time frame
6 months
3

Referrals to Alzheimer's disease specialists

Chart reviews will identify the number of patients with relevant referrals.

Time frame
6 months
4

Completed AD-relevant lab and neuroimaging studies

Chart reviews will identify the number of patients with completed orders.

Time frame
6 months

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Thomas Jefferson University

Lead sponsor

Independence Blue Cross

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: